ClinicalTrials.Veeva
Menu

Find clinical trials for Diabetes in Paris, Île-de-France

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Type 2 Diabetes Mellitus
Diabetes Mellitus
Obesity
Type 1 Diabetes Mellitus
Diabetic Foot
Overweight
Foot Ulcer

Diabetes trials near Paris, Île-de-France, FRA:

Interventional Clinical Trial Evaluating COVER PATCH CAPTEUR PROTECT Support Solutions for Continuous Glucose Monitoring Sensors in Patients With Diabetes (ICP-COVERPATCH)

and night, providing valuable data to help individuals manage their diabetes more efficiently. Many people face difficulties in keeping thei...

Enrolling
Diabetes
Device: Use of COVER patchs for continuous glucose monitoring sensor
CAPTEUR PROTECT

Corbeil-Essonnes, France and 6 other locations

Type 1 diabetes (T1D) is caused by the destruction of insulin-producing cells by effector T cells (Teffs), due to a deficiency of regulatory...

Enrolling
Type 1 Diabetes
Drug: Cyclosporin
Drug: ILT101

Phase 2

Assistance Publique - Hôpitaux de Paris

Paris, France

More than half of all new cases of type 1 diabetes (T1D) are diagnosed in the first decade of life. It has been reported that early onset T1...

Enrolling
Diabetes
Device: AIDS
Other: Brain MRI
Assistance Publique - Hôpitaux de Paris

Paris, France

also to as NMX8 system), in comparison with other commercially available AID systems (Automated insulin delivery) in adult patients with Type 1 diabetes...

Begins enrollment in 3 months
Type 1 Diabetes (T1D)
Device: AID Therapy
Device: NMX8 System - Control Arm
Medtronic
Medtronic

Paris, France and 19 other locations

The aim of the study is to determine whether NLRP3 inhibition with dapansutrile represents a new pharmacological option for diabetes managem....

Enrolling
Diabetes Mellitus, Type 2
Drug: Dapansutrile
Drug: Placebo

Phase 2

Marc Donath

Paris, Île-de-France Region, France and 5 other locations

The goal of this randomized controlled study is to assess the clinical performance and safety of Hedia Diabetes Assistant in adults with typ...

Enrolling
Type 1 Diabetes Mellitus (T1DM)
Device: Hedia Diabetes Assistant
Hedia

Paris, France and 5 other locations

To compare in diabetic patients eligible for percutaneous coronary intervention (PCI) with minimal exclusion criteria, the efficacy and safe...

Active, not recruiting
Diabetes
Coronary Artery Disease
Device: XIENCE Everolimus Eluting Coronary Stent System (XIENCE family)
Device: Abluminus DES+ Sirolimus Eluting Stent System (SES)
Concept Medical
Concept Medical

Paris, France and 89 other locations

This study will look at the effects of CagriSema in people with both type 2 diabetes and painful diabetic peripheral neuropathy, co...

Active, not recruiting
Diabetes Mellitus, Type 2
Diabetic Peripheral Neuropathy
Drug: CagriSema (Cagrilintide B and Semaglutide I)
Drug: Placebo matched to CagriSema (Cagrilintide B and Semaglutide I)

Phase 2

Novo Nordisk
Novo Nordisk

Paris, France and 54 other locations

This is a multicenter, randomized, placebo-controlled, 2-part study to evaluate the safety and efficacy of AT-001 in adult patients (N=675) with Diabetic...

Active, not recruiting
Diabetic Cardiomyopathies
Drug: AT-001
Drug: Placebo

Phase 3

Applied Therapeutics

Bondy, France and 78 other locations

Locations recently updated

Insulin Pump System (MIIPS 2020) in adult patients with Type 1 diabetes mellitus that cannot be controlled with subcutaneous insulin therapy...

Enrolling
Type I Diabetes
Device: Implantable Insulin Pump System
Medtronic
Medtronic

Paris, France and 5 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems